RETRACTED: HPV-16 Expression and Loss of Cell Differentiation in Primary Bladder Tumors (Retracted Article)

被引:1
|
作者
Pang, Lei [1 ]
Ding, Zijun [2 ]
Li, Fei [1 ]
Chai, Hongqiang [1 ]
Wu, Ming [1 ]
Shao, Jinkai [1 ]
机构
[1] Fifth Hosp Shanxi Med Univ, Shanxi Prov Peoples Hosp, Dept Urol, 29 Shuangta East St, Taiyuan 030012, Shanxi, Peoples R China
[2] Shanxi Childrens Hosp, Dept Neonatol, 13 North Xinmin St, Taiyuan 030013, Shanxi, Peoples R China
关键词
HUMAN-PAPILLOMAVIRUS; TISSUE; CANCER;
D O I
10.1155/2022/6565620
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objective. Primary bladder tumors have a high degree of malignancy. To investigate the expression of human papillomavirus type 16 (HPV-16) in primary bladder tumors and the loss of cell differentiation and to explore the significance of HPV-16 detection, it is expected to be a disease. Treatment provides a theoretical basis. Methods. Fifty-seven patients with primary bladder tumors admitted to our hospital from January 2019 to January 2022 were selected as the research subjects, and they were divided into HPV-related groups according to the human papillomavirus (HPV) infection status (n=28) and HPV unrelated group (n=29). The general data of patients were collected, the expression of HPV-16 in bladder tissue samples was detected, and the correlation between pathological parameters and HPV-16 expression was analyzed. Results. Among HPV subtypes, HPV 16 subtype accounted for the highest proportion, followed by HPV-18 and HPV-6 subtypes; there was no significant difference in tumor stage (stage 1, stage a, stage 2a) between the HPV-related group and the HPV-unrelated group (stage 1, stage a, and stage 2a). P > 0.05); there was no significant difference in postoperative pathological expression (high expression and low expression) of patients (P > 0.05); there was no statistical difference in age and gender between HPV-related and HPV-unrelated groups (P > 0.05), HPV-related group and HPV-unrelated group compared daily regular drinking and smoking status, the difference was statistically significant (P < 0.05); HPV-16 expression was not correlated with tumor differentiation degree and age of patients (P > 0.05); the area under the curve (AUC) of HPV-16 for judging primary bladder tumor expression and cellular molecular deletion was 0.891, with a sensitivity of 83.94% and a specificity of 88.57%. Conclusion. HPV-16 is an upper, expressed in primary bladder tumors and will participate in the differentiation and loss of cells, which can provide effective guidance and basis for the diagnosis of primary bladder tumors, which is an important factor for judging the pathological stage and prognosis of patients and can provide a theoretical reference for the formulation of therapeutic measures.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] RETRACTED: Activation of Toll-Like Receptor-9 Promotes Cellular Migration via Up-Regulating MMP-2 Expression in Oral Squamous Cell Carcinoma (Retracted Article)
    Ruan, Min
    Zhang, Zun
    Li, Siyi
    Yan, Min
    Liu, Shengwen
    Yang, Wenjun
    Wang, Lizheng
    Zhang, Chenping
    PLOS ONE, 2014, 9 (03):
  • [42] RETRACTED: DNA methylation-mediated repression of exosomal miR-652-5p expression promotes oesophageal squamous cell carcinoma aggressiveness by targeting PARG and VEGF pathways (Retracted Article)
    Gao, Peng
    Wang, Dan
    Liu, Meiyue
    Chen, Siyuan
    Yang, Zhao
    Zhang, Jie
    Wang, Huan
    Niu, Yi
    Wang, Wei
    Yang, Jilong
    Sun, Guogui
    PLOS GENETICS, 2020, 16 (04):
  • [43] RETRACTED: Bergamottin isolated from Citrus bergamia exerts in vitro and in vivo antitumor activity in lung adenocarcinoma through the induction of apoptosis, cell cycle arrest, mitochondrial membrane potential loss and inhibition of cell migration and invasion (Retracted Article)
    Wu, Hui-Juan
    Wu, Hong-Bo
    Zhao, Yan-Qiu
    Chen, Li-Juan
    Zou, Hong-Zhi
    ONCOLOGY REPORTS, 2016, 36 (01) : 324 - 332
  • [44] RETRACTED: Decreased expression of long noncoding RNA XLOC_013703 promotes cell growth via NF-κB pathway in multiple myeloma (Retracted article. See MAY, 2023)
    Pu, Jiang
    Huang, Hongming
    Su, Jianyou
    Yuan, Jie
    Cong, Hui
    Wang, Xudong
    Ju, Shaoqing
    IUBMB LIFE, 2019, 71 (09) : 1240 - 1251
  • [45] RETRACTED: lncRNA XIST promotes the progression of laryngeal squamous cell carcinoma by sponging miR-144 to regulate IRS1 expression (Retracted article. See vol. 46, 2021)
    Cui, Chang-Lei
    Li, Yi-Ning
    Cui, Xiang-Yan
    Wu, Xin
    ONCOLOGY REPORTS, 2020, 43 (02) : 525 - 535
  • [46] RETRACTED: Differential expression of miR-130a-3p modulate ovarian epithelial carcinoma (OEC) cell development and could be a biomarker for OEC (Retracted article. See vol. 150, 2022)
    Alrashed, May Mohammed
    Ahmad, Mohammad
    Yongmei, Wei
    Xiuyeng, Wang
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2021, 145
  • [47] RETRACTED: MicroRNA-381 enhances radiosensitivity in esophageal squamous cell carcinoma by targeting X-linked inhibitor of apoptosis protein (Retracted article. See vol. 16, pg. 311, 2023)
    Zhou, Suna
    Cui, Yaoyou
    Yu, Dequan
    Liang, Jun
    Zhang, Mingxin
    Ye, Wenguang
    ONCOTARGETS AND THERAPY, 2017, 10 : 2527 - 2538
  • [48] RETRACTED: Correlation between ER, PR, P53, Ki67 expression, and high-risk HPV infection in patients with different levels of cervical intraepithelial neoplasia (Retracted article. See vol. 21, 2023)
    Yuan, Gao
    EUROPEAN JOURNAL OF INFLAMMATION, 2020, 18
  • [49] RETRACTED: The role of CRP and ATG9B expression in clear cell renal cell carcinoma (Publication with Expression of Concern) (Publication with Expression of Concern. See vol. 43, pg. 1082, 2023) (Retracted article. See vol. 43, 2023)
    Ma, Zheng
    Qi, Zengguang
    Shan, Zhengfei
    Li, Jiangsong
    Yang, Jing
    Xu, Zhonghua
    BIOSCIENCE REPORTS, 2017, 37
  • [50] RETRACTED: Circ-DENND4C up-regulates TCF4 expression to modulate hepatocellular carcinoma cell proliferation and apoptosis via activating Wnt/β-catenin signal pathway (Retracted Article)
    Liu, Xialei
    Yang, Lewei
    Jiang, Dong
    Lu, Wuzhu
    Zhang, Yongyu
    CANCER CELL INTERNATIONAL, 2020, 20 (01)